A former leader of Operation Warp Speed’s vaccines effort, which led to a quick rollout of Covid jabs, is getting federal funding for his biotech’s work on the next generation of Covid therapeutics.
The big-time BARDA contracts keep rolling in, this time for infectious disease biotech and Merck partner ModeX Therapeutics.